Director, Clinical Research Division

Nathan Kline Institute for Psychiatric Research

                 Dr. Dan Iosifescu is Director of the Clinical Research Division at the Nathan Kline Institute and Associate Professor of Psychiatry at the New York University School of Medicine.  His research is focused on novel pharmacological treatments (such as ketamine and other glutamatergic drugs) and devices (such as photobiomodulation with near infrared light and novel forms of magnetic stimulation) for patients with severe mood disorders (major depression and bipolar disorder) and mild cognitive impairment (MCI).  In his research Dr. Iosifescu uses neuroimaging (MRI, MRS, PET) and neurophysiology (quantitative EEG) techniques to evaluate structural, biochemical, and functional brain abnormalities in mood disorders and their impact on clinical treatment.  In parallel Dr. Iosifescu also focuses on the recognition and treatment of cognitive deficits associated with mood disorders and MCI.